These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36224480)

  • 1. Total Neoadjuvant Therapy Is a Predictor for Complete Pathological Response in Patients Undergoing Surgery for Rectal Cancer.
    Horesh N; Freund MR; Garoufalia Z; Gefen R; Nagarajan A; Suarez E; Emile SH; Wexner SD
    J Gastrointest Surg; 2022 Dec; 26(12):2579-2584. PubMed ID: 36224480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 4. [Application of short-course radiotherapy with total neoadjuvant therapy in the treatment of middle and low rectal cancer].
    Chen CJ; Yang CK; Jian JL; Guan S; Xie MM
    Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(4):271-277. PubMed ID: 36660788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 6. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
    Kasi A; Abbasi S; Handa S; Al-Rajabi R; Saeed A; Baranda J; Sun W
    JAMA Netw Open; 2020 Dec; 3(12):e2030097. PubMed ID: 33326026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes.
    Soomro MY; Khan SR; Muhammad H; Ahmad S; Zehra N; Ali I; Samar MR; Hameed A; Moosajee M; Rashid YA
    BMC Cancer; 2024 Apr; 24(1):479. PubMed ID: 38627736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Outcomes in Total Neoadjuvant Therapy for Rectal Cancer Versus Standard Long-course Chemoradiation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lin W; Li C; Clement EA; Brown CJ; Raval MJ; Karimuddin AA; Ghuman A; Phang PT
    Ann Surg; 2024 Apr; 279(4):620-630. PubMed ID: 38009646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer: A Comparison of Short- and Long-term Oncologic Outcomes.
    Goffredo P; Khan A; Mott SL; Jensen CC; Madoff RD; Gaertner WB; You YN; Hassan I
    Ann Surg; 2022 Dec; 276(6):e819-e824. PubMed ID: 34353995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of MRI-detected extramural vascular invasion in stage T3 rectal cancer patients before neoadjuvant chemoradiation.
    Sun Y; Li J; Shen L; Wang X; Tong T; Gu Y
    Diagn Interv Radiol; 2018; 24(3):128-134. PubMed ID: 29770764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer.
    Bratu LD; Schenker M; Stovicek PO; Schenker RA; Mehedințeanu AM; Berisha TC; Donoiu A; Mogoantă SȘ
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674302
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluating complete response rates and predictors in total neoadjuvant therapy for rectal cancer.
    Erozkan K; Elamin D; Tasci ME; Liska D; Valente MA; Alipouriani A; Schabl L; Lavryk O; Catalano B; Krishnamurthi S; Miller JA; Purysko AS; Steele SR; Gorgun E
    J Gastrointest Surg; 2024 Oct; 28(10):1605-1612. PubMed ID: 39067745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival.
    Zhang H; Li G; Cao K; Zhai Z; Wei G; Qu H; Wang Z; Han J
    Int J Colorectal Dis; 2022 Jul; 37(7):1657-1668. PubMed ID: 35716183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Zhang Q; Liang J; Chen J; Mei S; Wang Z
    Asian Pac J Cancer Prev; 2021 May; 22(5):1607-1611. PubMed ID: 34048192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low- Versus High-Risk Rectal Cancer Based on MRI Features: Outcomes in Patients Treated Without Neoadjuvant Chemoradiotherapy.
    Jia XX; Wang Y; Cheng J; Yao X; Yin MJ; Zhou J; Ye YJ
    AJR Am J Roentgenol; 2018 Aug; 211(2):327-334. PubMed ID: 29927331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Lutsyk M; Awawda M; Gourevich K; Ben Yosef R
    Am J Clin Oncol; 2021 Sep; 44(9):482-486. PubMed ID: 34269693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion.
    Prampolini F; Taschini S; Pecchi A; Sani F; Spallanzani A; Gelsomino F; Kaleci S; Torricelli P
    Abdom Radiol (NY); 2020 Oct; 45(10):2941-2949. PubMed ID: 30483843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients.
    Mei SW; Liu Z; Wei FZ; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Pei W; Wang Z; Wang XS; Liu Q
    World J Gastroenterol; 2020 Aug; 26(31):4624-4638. PubMed ID: 32884221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.